Get Started

PLX

AMEX Protalix Biotherapeutics, Inc.
Nov 13, 2026 · 7:09 PM ET LAST TRADE Market Closed

$3.05 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.05, and at the day’s high of $3.05

YTD change
+69.44%
vs 20-day SMA
+15.66%
vs 200-day SMA
+24.85%

Price ranges

Previous day
$2.92 $3.13
open $3.12 close $2.96
-$0.16 (-5.13%)
Today
$2.85 $3.05
open $2.94 now $3.05
+$0.11 (+3.74%)
Past week
$2.45 $3.14
from $2.51 now $3.05
+$0.54 (+21.51%)
Past month
$2.45 $3.14
from $2.70 now $3.05
+$0.35 (+12.96%)
This year
$1.72 $3.19
from $1.80 now $3.05
+$1.25 (+69.44%)

Price & Performance

+1.03 (+53.37%) / 6M

$1.80$2.28$2.75$3.23May 13Aug 13Nov 12

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 79.9% away from all-time highs of $15.15
  • PLX is up 69% since the beginning of the year
  • PLX is up 58% over the past 12 months
  • PLX is up 13% over the past 1 month
  • 5% of all PLX investors are betting against PLX
  • Number of investors short PLX has gone up 21% versus last month

PLX reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +53.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.05
Earnings momentum +225.0% Quarterly EPS growth
Quarterly change +225.0%

Valuation

P/E ratio 13.61
Enterprise value $207.3M
Beta 0.06

Balance sheet & scale

Income$20.6K
Revenue$84.7M
Cash$49.3M
Debt$9.1K
Income / Debt 2.25×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeAMEX
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $257.2M

Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $467.06 -0.22%
MRNA Moderna, Inc. $231.35 -6.97%
RVMD Revolution Medicines, Inc. $176.35 -2.41%
ROIV Roivant Sciences Ltd. $39.99 -4.44%
BNTX BioNTech SE Sponsored ADR $85.04 -2.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.